We were stuck for a couple days in a Nobel vortex. Speculation about a Nobel Prize in chemistry for University of California, Berkeley scientist Jennifer Doudna and her gene-editing research partner, Emmanuelle Charpentier, swirled and swirled until everyone following it got... Read more »
Another Boston-area robotics company has raised venture capital. But this one isn’t saying much about what it’s building yet.
RightHand Robotics, a Harvard University spinout based at the Harvard Innovation Lab, has raised $3.3 million, according to a regulatory... Read more »
Techstars has made its views on diversity in the tech sector no secret. The Boulder, CO-based accelerator operator made commitments to the White House earlier this year, alongside various other prominent national organizations, to improve diversity in the industry by doubling... Read more »
It was a busy week of fundraising and mergers and acquisitions in Boston tech. Here are some of the latest deals:
—Skyworks Solutions (NASDAQ: SWKS), the Woburn, MA-based chipmaker whose customers include Apple, said it will acquire Sunnyvale, CA-based semiconductor... Read more »
Biomedical innovation is shaking up societies around the world, prompting advances no one would have imagined a decade ago, and stirring debates about ethical and financial costs. The San Francisco Bay Area is teeming with people, companies, and ideas at the... Read more »
Donald Ingber is known as a pioneer in the organ-on-a-chip field. But the founding director of Harvard University’s Wyss Institute apparently has some other ideas up his sleeve—like a method of clearing dangerous infections from the blood, a technology that has... Read more »
Austin, TX cleantech startup Curb has nabbed $1.25 million in investment that comes after the company ran a successful Indiegogo campaign that was oversubscribed by more than 300 percent.
In August, Curb raised $120,000 through crowdfunding. That helped the company raise... Read more »
Runaway valuations and the piles of money pouring into hot tech startups grab lots of headlines these days. That can make it easy to forget about traditional small businesses that might not have as much job-growth potential as startups, but still... Read more »
CytomX Therapeutics has fought through biotech’s downward slide to emerge as a public company. The South San Francisco, CA-based drug maker raised $80 million in its initial public offering, and its shares should start trading on the Nasdaq Thursday under the... Read more »